Boothbay Fund Management, LLC Bristol Myers Squibb CO Transaction History

Boothbay Fund Management, LLC

  • $5.7 Billion
  • Q3 2025

A detailed history of Boothbay Fund Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 9,481 shares of BMY stock, worth $443,805. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,481
Previous 29,564 67.93%
Holding current value
$443,805
Previous $1.37 Million 68.79%
% of portfolio
0.01%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$43.31 - $48.98 $869,794 - $983,665
-20,083 Reduced 67.93%
9,481 $427,000
Q2 2025

Aug 14, 2025
BUY
$44.12 - $59.6 $891,841 - $1.2 Million
20,214 Added 216.19%
29,564 $1.37 Million
Q1 2025

May 15, 2025
SELL
$53.9 - $63.11 $920,989 - $1.08 Million
-17,087 Reduced 64.63%
9,350 $570,000
Q4 2024

Feb 14, 2025
BUY
$51.92 - $59.94 $1.37 Million - $1.58 Million
26,437 New
26,437 $1.5 Million
Q3 2023

Nov 14, 2023
BUY
$57.89 - $64.73 $973,073 - $1.09 Million
16,809 New
16,809 $975,000
Q1 2023

May 15, 2023
BUY
$65.71 - $74.53 $4.53 Million - $5.14 Million
68,956 Added 1382.44%
73,944 $5.13 Million
Q4 2022

Feb 14, 2023
SELL
$68.48 - $81.09 $3.57 Million - $4.23 Million
-52,106 Reduced 91.26%
4,988 $358,000
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $7,422 - $4.39 Million
57,094 New
57,094 $4.06 Million
Q4 2021

Feb 14, 2022
SELL
$53.63 - $62.52 $1.29 Million - $1.51 Million
-24,137 Reduced 33.26%
48,439 $3.02 Million
Q3 2021

Nov 15, 2021
SELL
$59.17 - $69.31 $6.08 Million - $7.12 Million
-102,756 Reduced 58.61%
72,576 $4.29 Million
Q2 2021

Aug 16, 2021
BUY
$61.91 - $67.42 $2.15 Million - $2.34 Million
34,680 Added 24.66%
175,332 $3.26 Million
Q1 2021

May 17, 2021
BUY
$59.34 - $66.74 $5.95 Million - $6.69 Million
100,252 Added 248.15%
140,652 $736,000
Q4 2020

Feb 12, 2021
BUY
$57.74 - $65.43 $864,483 - $979,617
14,972 Added 58.88%
40,400 $2.51 Million
Q3 2020

Nov 16, 2020
SELL
$57.43 - $63.64 $1.73 Million - $1.92 Million
-30,127 Reduced 54.23%
25,428 $1.53 Million
Q2 2020

Aug 14, 2020
SELL
$54.82 - $64.09 $174,930 - $204,511
-3,191 Reduced 5.43%
55,555 $3.27 Million
Q1 2020

May 15, 2020
BUY
$46.4 - $67.43 $512,905 - $745,371
11,054 Added 23.18%
58,746 $3.28 Million
Q4 2019

Feb 14, 2020
BUY
$49.21 - $64.19 $1.64 Million - $2.14 Million
33,361 Added 232.79%
47,692 $3.06 Million
Q3 2019

Nov 14, 2019
BUY
$42.77 - $50.71 $612,936 - $726,725
14,331 New
14,331 $727,000
Q2 2019

Aug 14, 2019
SELL
$44.62 - $49.34 $609,330 - $673,787
-13,656 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$45.12 - $53.8 $616,158 - $734,692
13,656 New
13,656 $652,000

Others Institutions Holding BMY

# of Institutions
2,680
Shares Held
1.58B
Call Options Held
28M
Put Options Held
28.4M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email